Civic Intelligence

Eicosanoid Research Foundation C/O Dr Kenneth V Honn

EIN 27-0097769 • 501(c)3 • Detroit, MI

Profile

The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's biennial conference. The eicosanoid research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer,

5101 Cass Avenue 435 Chemistry BldDetroit, MI 48202

www.eicosanoidresearchfoundation.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

1st percentile

-0.07x

Higher debt load relative to assets than 1% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Liabilities / Revenue

1st percentile

-0.04x

Higher debt load relative to revenue than 1% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Net Margin

19th percentile

-32%

Higher net margin than 19% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2023

Asset Growth

23rd percentile

-40%

Faster asset growth than 23% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Revenue Growth

6th percentile

-92%

Faster revenue growth than 6% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Balance Sheet
Liabilities / Assets1st percentile

Assets

Down

$10,801

Down $7,088 (-40%) from 2022

Liabilities

Down

-$742

Down $742 from 2022

Net Assets

Down

$11,543

Down $6,346 (-35%) from 2022

Operations
Liabilities / Revenue1st percentileNet Margin19th percentile

Revenue

Down

$20,080

Down $245,668 (-92%) from 2022

Expenses

Down

$26,426

Down $305,671 (-92%) from 2022

Net Income

Up

-$6,346

Up $60,003 (+90%) from 2022

Trend Graphs

Balance Sheet Trend

Asset Growth23rd percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$100K$50K$0-$50KAssets 2011: $65,562Liabilities 2011: $0Net Assets 2011: $65,5622011Assets 2012: $44,754Net Assets 2012: $44,7542012Assets 2013: $831Net Assets 2013: $8312013Assets 2014: $14,630Net Assets 2014: $14,6302014Assets 2015: $12,688Net Assets 2015: $12,6882015Assets 2016: $39,489Net Assets 2016: $39,4892016Assets 2017: $71,362Liabilities 2017: $0Net Assets 2017: $71,3622017Assets 2018: $45,889Liabilities 2018: $3,020Net Assets 2018: $42,8692018Assets 2019: $77,621Liabilities 2019: $0Net Assets 2019: $77,6212019Assets 2020: $27,594Liabilities 2020: $1,699Net Assets 2020: $25,8952020Assets 2021: $88,983Liabilities 2021: $4,745Net Assets 2021: $84,2382021Assets 2022: $17,889Liabilities 2022: $0Net Assets 2022: $17,8892022Assets 2023: $10,801Liabilities 2023: -$742Net Assets 2023: $11,5432023

Highlighted filing

2023

Assets$10,801
Liabilities-$742
Net Assets$11,543
Open 2023 Filing

Operations Trend

Revenue Growth6th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$300K$200K$100K$0-$100KExpenses 2011: $303,4022011Revenue 2012: $445Expenses 2012: $21,253Net Income 2012: -$20,8082012Revenue 2013: $176,062Expenses 2013: $219,985Net Income 2013: -$43,9232013Revenue 2014: $36,573Expenses 2014: $22,774Net Income 2014: $13,7992014Revenue 2015: $165,204Expenses 2015: $167,146Net Income 2015: -$1,9422015Revenue 2016: $46,961Expenses 2016: $14,415Net Income 2016: $32,5462016Revenue 2017: $255,293Expenses 2017: $227,286Net Income 2017: $28,0072017Revenue 2018: $28,463Expenses 2018: $56,956Net Income 2018: -$28,4932018Revenue 2019: $261,031Expenses 2019: $226,279Net Income 2019: $34,7522019Revenue 2020: $5,003Expenses 2020: $56,729Net Income 2020: -$51,7262020Revenue 2021: $78,803Expenses 2021: $20,460Net Income 2021: $58,3432021Revenue 2022: $265,748Expenses 2022: $332,097Net Income 2022: -$66,3492022Revenue 2023: $20,080Expenses 2023: $26,426Net Income 2023: -$6,3462023

Highlighted filing

2023

Revenue$20,080
Expenses$26,426
Net Income-$6,346
Open 2023 Filing

Filings

Most recent year

2023 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$10,801
Liabilities
-$742
Net assets
$11,543
Revenue
$20,080
Expenses
$26,426
Net income
-$6,346
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$0.11$0.01$0.12$0.20$0.26$0.06
2022Detailed filing. Detailed filing data is available for this year.$0.18$0.00$0.18$2.66$3.32$0.66
2021Detailed filing. Detailed filing data is available for this year.$0.89$0.05$0.84$0.79$0.20$0.58
2020Detailed filing. Detailed filing data is available for this year.$0.28$0.02$0.26$0.05$0.57$0.52
2019Detailed filing. Detailed filing data is available for this year.$0.78$0.00$0.78$2.61$2.26$0.35
2018Detailed filing. Detailed filing data is available for this year.$0.46$0.03$0.43$0.28$0.57$0.28
2017Detailed filing. Detailed filing data is available for this year.$0.71$0.00$0.71$2.55$2.27$0.28
2016Detailed filing. Detailed filing data is available for this year.$0.39$0.39$0.47$0.14$0.33
2015Detailed filing. Detailed filing data is available for this year.$0.13$0.13$1.65$1.67$0.02
2014Detailed filing. Detailed filing data is available for this year.$0.15$0.15$0.37$0.23$0.14
2013Detailed filing. Detailed filing data is available for this year.$0.01$0.01$1.76$2.20$0.44
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.45$0.45$0.00$0.21$0.21
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.66$0.00$0.66$3.03
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
May 8, 2024
Return Version
2023v5.0
Gross Receipts
$20,080
Mission and Program Overview

Mission

The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's bi-annual conference. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds.the main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer

The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's biennial conference. The eicosanoid research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer,

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$17,889$10,801▼ $7,088
Total Assets$17,889$10,801▼ $7,088
Liabilities
Accounts Payable and Accrued Expenses-$-742-
Total Liabilities$0$-742▼ $742
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$17,889$11,543▼ $6,346
Total Net Assets Fund Balance$17,889$11,543▼ $6,346
Total Liabilities and Net Assets / Fund Balance$17,889$10,801▼ $7,088
Compensation and Service Providers
Top Officer Pay81st percentile

Board Members and Trustees

NameTitle
Charles SerhanPresident
Edward DennisDirector
Gabor TigyiDirector
Makoto AritaDirector
Takehiko YokomizoDirector
Krishnarao MaddipatiTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$18,956
Program Service Revenue
$0
Investment Income
$2
Other Revenue
$1,122
Change in Net Assets
$-6,346
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$26,426
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Travel$8,882--$8,882
Fees for Services Legal$7,330--$7,330
Advertising$1,700--$1,700
Other Expenses$600$1,083-$600
Office Expenses-$272-$272
Conferences and Meetings$258--$258
All Other Expenses$198$20-$218
Total Functional Expenses$25,051$1,375$0$26,426
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Backup withholding compliance
No
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“No review was or will be conducted”

Form 990, Page 6, Part VI, Line 12C

“Annual completion of conflict of interest and commitment disclosure form”

Form 990, Page 6, Part VI, Line 19

“No other documents available to the public”

Filing and Contact Details

Filer

Filer Name
Eicosanoid Research Foundation
EIN
27-0097769
Phone
3135772999
Address
5101 CASS AVENUE 435 CHEMISTRY BLD, DETROIT, MI 48202

Signing Officer

Name
Charles Serhan
Title
President
Phone
3135772999
Signed
2024-05-08
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Charles Serhan
Formed
2004
Voting Board Members
6
Independent Board Members
6
Employees
0

Preparer

Firm
Alan C Young & Associates Pc
Address
7310 WOODWARD AVE STE 740, DETROIT, MI 48202
Preparer
Alan C Young
Phone
3138737500
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's biennial conference. The eicosanoid research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer, inflammation and related diseases thereby promoting advances in this area of science and medical research. The foundation also organizes, supports and hosts the annual wayne state university lipids symposium. The symposium addresses the vital roles of lipids in cellular processes required for normal physiological function.”

Form 990, Part XI, Line 9

“OPENING BALANCE EQUITY 0”

Raw XML Appendix314 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0-742
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER,
IRS990/AdvertisingGrp/ProgramServicesAmt01700
IRS990/AdvertisingGrp/TotalAmt01700
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt020
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0198
IRS990/AllOtherExpensesGrp/TotalAmt0218
IRS990/BackupWthldComplianceInd0false
IRS990/BooksInCareOfDetail/PersonNm0CHARLES SERHAN
IRS990/BooksInCareOfDetail/PhoneNum03135772999
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt05101 CASS AVENUE 431 CHEMISTRY BLD
IRS990/BooksInCareOfDetail/USAddress/CityNm0DETROIT
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MI
IRS990/BooksInCareOfDetail/USAddress/ZIPCd048202
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt017889
IRS990/CashNonInterestBearingGrp/EOYAmt010801
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0258
IRS990/ConferencesMeetingsGrp/TotalAmt0258
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt018956
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt02
IRS990/CYOtherExpensesAmt026426
IRS990/CYOtherRevenueAmt01122
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-6346
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt026426
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt020080
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0BIENNIAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2022 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, INCLUDING CANCER. THIS WAS THE 17TH INTERNATIONAL CONFERENCE SCHEDULED IN NEW ORLEANS, LOUISIANA, USA FROM OCTOBER 30 - NOVEMBER 2, 2022. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR DIEASE AND THE RESOLUTIN OF IMFLAMMATORY DISEASES.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt025051
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt07330
IRS990/FeesForServicesLegalGrp/TotalAmt07330
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0CHARLES SERHAN
IRS990/Form990PartVIISectionAGrp/PersonNm1KRISHNARAO MADDIPATI
IRS990/Form990PartVIISectionAGrp/PersonNm2MAKOTO ARITA
IRS990/Form990PartVIISectionAGrp/PersonNm3EDWARD DENNIS
IRS990/Form990PartVIISectionAGrp/PersonNm4GABOR TIGYI
IRS990/Form990PartVIISectionAGrp/PersonNm5TAKEHIKO YOKOMIZO
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt06
IRS990/GovernmentGrantsAmt018956
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt020080
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt06
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt02
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt02
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER,
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt017889
IRS990/NetAssetsOrFundBalancesEOYAmt011543
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt017889
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt011543
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0272
IRS990/OfficeExpensesGrp/TotalAmt0272
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherExpensesGrp/Desc0SPEAKER MEALS
IRS990/OtherExpensesGrp/Desc1CONTRACTORS
IRS990/OtherExpensesGrp/Desc2WEBSITE/COMPUTER EXPENSE
IRS990/OtherExpensesGrp/Desc3POSTER AWARDS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt01083
IRS990/OtherExpensesGrp/ProgramServicesAmt03664
IRS990/OtherExpensesGrp/ProgramServicesAmt12419
IRS990/OtherExpensesGrp/ProgramServicesAmt2600
IRS990/OtherExpensesGrp/TotalAmt03664
IRS990/OtherExpensesGrp/TotalAmt12419
IRS990/OtherExpensesGrp/TotalAmt21083
IRS990/OtherExpensesGrp/TotalAmt3600
IRS990/OtherRevenueMiscGrp/Desc0OTHER INCOME
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt01122
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt01122
IRS990/OtherRevenueTotalAmt01122
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0CHARLES SERHAN
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgSrvcAccomActy2Grp/Desc0ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM: THE WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS IN CELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION. THE 7TH WSU LIPIDS SYMPOSIUM WAS SCHEDULED FOR MAY 13, 2020 IN THE STUDENT BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY. DUE TO THE COVID-19 PANDEMIC, THE EVENT WAS CANCELED. THE SYMPOSIUM HAS BEEN SUSPENDED SINCE THAT POINT, BUT IS CURRENTLY EXPECTED TO RESUME IN EITHER 2023 OR 2024. PREVIOUSLY, THE (6TH) WSU LIPIDS SYMPOSIUM WAS HELD IN THE STUDENT CENTER BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY ON MAY 7, 2019 AND WAS WELL ATTENDED.
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0139190
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt017
IRS990/PYOtherExpensesAmt0332097
IRS990/PYProgramServiceRevenueAmt0126541
IRS990/PYRevenuesLessExpensesAmt0-66349
IRS990/PYTotalExpensesAmt0332097
IRS990/PYTotalRevenueAmt0265748
IRS990/ReconcilationRevenueExpnssAmt0-6346
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt018956
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0139190
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt072875
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt05000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt095299
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0331320
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt017
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt023
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt01124
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0126558
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt05925
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0165715
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0299322
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt017
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt023
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct00.99990
IRS990ScheduleA/PublicSupportTotal509Amt0630642
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt020080
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0265748
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt078800
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt05000
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0261014
IRS990ScheduleA/Total509Grp/TotalAmt0630642
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt020080
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0265748
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt078803
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt05003
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0261031
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0630665
IRS990/ScheduleBRequiredInd0false
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RESEARCH. THE FOUNDATION ALSO ORGANIZES, SUPPORTS AND HOSTS THE ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM. THE SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS IN CELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1NO REVIEW WAS OR WILL BE CONDUCTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2ANNUAL COMPLETION OF CONFLICT OF INTEREST AND COMMITMENT DISCLOSURE FORM
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO OTHER DOCUMENTS AVAILABLE TO THE PUBLIC
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4OPENING BALANCE EQUITY 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt017889
IRS990/TotalAssetsEOYAmt010801
IRS990/TotalAssetsGrp/BOYAmt017889
IRS990/TotalAssetsGrp/EOYAmt010801
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt018956
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt01375
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt025051
IRS990/TotalFunctionalExpensesGrp/TotalAmt026426
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesEOYAmt0-742
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt0-742
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt017889
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt011543
IRS990/TotalProgramServiceExpensesAmt025051
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt01124
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt020080
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt017889
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt010801
IRS990/TravelGrp/ProgramServicesAmt08882
IRS990/TravelGrp/TotalAmt08882
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/USAddress/AddressLine1Txt05101 CASS AVENUE 431 CHEMISTRY BLD
IRS990/USAddress/CityNm0DETROIT
IRS990/USAddress/StateAbbreviationCd0MI
IRS990/USAddress/ZIPCd048202
IRS990/VotingMembersGoverningBodyCnt06
IRS990/VotingMembersIndependentCnt06
IRS990/WebsiteAddressTxt0WWW.EICOSANOIDRESEARCHFOUNDATION.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0CHARLES SERHAN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum03135772999
ReturnHeader/BusinessOfficerGrp/SignatureDt02024-05-08
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0EICOSANOID RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0C/O KRISHNARAO MADDIPATI
ReturnHeader/Filer/BusinessNameControlTxt0EICO
ReturnHeader/Filer/EIN0270097769
ReturnHeader/Filer/PhoneNum03135772999
ReturnHeader/Filer/USAddress/AddressLine1Txt05101 CASS AVENUE 435 CHEMISTRY BLD
ReturnHeader/Filer/USAddress/CityNm0DETROIT
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MI
ReturnHeader/Filer/USAddress/ZIPCd048202
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0382463166
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0ALAN C YOUNG & ASSOCIATES PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt07310 WOODWARD AVE STE 740
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0DETROIT
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MI
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd048202
ReturnHeader/PreparerPersonGrp/PhoneNum03138737500
ReturnHeader/PreparerPersonGrp/PreparationDt02024-05-13
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ALAN C YOUNG
ReturnHeader/ReturnTs02024-05-14T07:54:39-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0CHARLES
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0SERHAN
ReturnHeader/TaxPeriodBeginDt02023-01-01
ReturnHeader/TaxPeriodEndDt02023-12-31
ReturnHeader/TaxYr02023

Document Assets

No mirrored PDF or thumbnail assets are attached yet.